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Metazoan replication-dependent histone mRNAs end in a stem-loop sequence. The one known exception is
the histone mRNA in amphibian oocytes, which has a short oligo(A) tail attached to the stem-loop sequence.
Amphibian oocytes also contain two proteins that bind the 3 end of histone mRNA: xSLBP1, the homologue
of the mammalian SLBP, and xSLBP2, which is present only in oocytes. xSLBP2 is an inhibitor of histone
mRNA translation, while xSLBP1 activates translation. The short A tail on histone mRNAs appears at stage
II to III of oogenesis and is present on histone mRNAs throughout the rest of oogenesis. At oocyte maturation,
the oligo(A) tail is removed and the xSLBP2 is degraded, resulting in the activation of translation of histone
mRNA. Both SLBPs bind to the stem-loop with the oligo(A) tail with similar affinities. Reporter mRNAs ending
in the stem-loop with or without the oligo(A) tail are translated equally well in a reticulocyte lysate, and their
translation is stimulated by the presence of xSLBP1. In contrast, translation of the reporter mRNA with an
oligo(A) tail is not activated in frog oocytes in response to the presence of xSLBP1. These results suggest that
the oligo(A) tail is an active part of the translation repression mechanism that silences histone mRNA during
oogenesis and that its removal is part of the mechanism that activates translation.
During Xenopus oogenesis and early embryogenesis, much
of the control of gene activity is a result of programmed trans-
lational regulation (4, 12, 36). Since there is no transcription
until the midblastula transition (21), the oocyte and early em-
bryo rely on regulation of the stored maternal mRNAs to
modulate the pattern of protein synthesis. One set of proteins
whose synthesis is regulated during oogenesis and early em-
bryogenesis is that of the histone proteins (1, 39). The mRNAs
encoding all five classes of histone proteins are unique among
metazoan mRNAs in that they are the only known mRNAs
that lack poly(A) tails and end instead in a conserved stem-
loop sequence (16, 18). This stem-loop is a critical cis-acting
element involved in all aspects of histone mRNA biosynthesis
across different species (17). Over 25 years ago it was reported
that histone mRNAs from Xenopus oocytes are polyadenylated
(15). These amphibian transcripts have an A tail added directly
to the stem-loop (2).
Histone mRNAs are synthesized early in oogenesis, and
synthesis is complete by the end of stage II of oogenesis. The
histone mRNAs are also translated in stage II to provide a
maternal store of histone proteins (39). In later stages of oo-
genesis there is little or no translation of the histone mRNA
(39). When full-grown stage VI oocytes are treated with pro-
gesterone, they undergo maturation, initiating progression
through meiosis, and also activate a translational regulation
program necessary for the initial stages of embryogenesis. One
of the mRNAs activated at oocyte maturation is histone
mRNA (1).
The 3 end of histone mRNA is essential for efficient trans-
lation (9, 25). In Xenopus oocytes there are two stem-loop
binding proteins (SLBPs) that can bind the 3 end of histone
mRNAs: xSLBP1 and xSLBP2 (33). xSLBP1, which is the or-
thologue of the mammalian SLBP, is required for histone
pre-mRNA processing (13), and it is also necessary for efficient
translation of histone mRNA (25). In contrast, xSLBP2 is
found only in oocytes and does not support translation of
histone mRNA. xSLBP2 is associated with the maternally
stored histone mRNA and is destroyed during oocyte matura-
tion (33). The destruction of xSLBP2 may allow xSLBP1 to
bind to the mRNA, activating its translation.
Histone mRNAs in Xenopus oocytes contain a short A tail,
which is attached to the stem-loop (2). We report here that the
oligo(A) tail plays an active role in translation repression.
Histone mRNAs ending with an oligo(A) tail are not trans-
lated in the presence of xSLBP1 in Xenopus oocytes, although
they are translated in reticulocyte lysates. In addition to
xSLBP2, the oligo(A) tail also plays a role in repression of
histone mRNA translation.
MATERIALS AND METHODS
Construction of SLBP, histone, and luciferase clones. The construction of
vectors encoding xSLBP1, xSLBP2, human SLBP (hSLBP), MS2, and MS2-
hSLBP and the luciferase mRNAs ending in the stem-loop, tetraloop (TL), and
MS2 sequences have been described previously (25). To generate the Luc-SLA8/
SLC8/SLN8 genes, two complementary oligonucleotides encoding the histone
stem-loop sequence followed by eight adenosines, eight cytosines, or the se-
quence GATTACAG were annealed and ligated into the Luc-SL vector digested
with BamHI and AflII. A similar strategy was used to construct the Luc-MS2A8
gene.
S1 nuclease mapping. To map the 3 end of the histone mRNA, we used two
different probes. The S1 probe used to map the 3 end of the histone xH2a
mRNA (Fig. 1B) was generated by PCR, using a previously cloned Xenopus H2a
cDNA ending in 20 adenosines as the template (33). Standard RNAs ending in
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FIG. 1. Oocyte histone mRNA contains an oligo(A) tail. (A) The
structures of the 3 ends of the egg (left panel) and oocyte (right panel)
histone mRNAs are shown. The S1 nuclease protection assay used to
determine the length of the poly(A) tail is diagrammed. (B) The S1
nuclease assay (as shown in panel A) was used to map the 3 end of
Xenopus histone H2a mRNA in stage III and stage VI oocytes and
matured oocytes. Synthetic RNAs ending in the ACCCA sequence
formed by histone pre-mRNA processing (lane 3) or ending in the
ACCCA followed by 25 As (lane 4) were incubated with the probe
containing 20 Ts after the stem-loop. The reaction mixtures were
treated with S1 nuclease, resulting in a fragment of 130 nt resulting
from protection of the ACCCA (lane 3) and a 150-nt fragment result-
ing from protection of the A20 tail (lane 4). For lanes 5 to 7, total cell
RNA from one oocyte equivalent of RNA from stage III, stage VI, or
matured oocytes (m) was incubated with the probe, the reaction mix-
tures were treated with S1 nuclease, and the protected fragments were
analyzed on a 60-cm-long 8% polyacrylamide–7 M urea gel. Lane 1, a
184-nt probe; lane 2 (L), pUC18 digested with HpaII and labeled with
[-32P]dCTP. The sizes of these fragments are indicated. The fragment
at about 175 nt in lanes 1 to 5 is derived from the probe. (C) RNA from
one oocyte or egg was analyzed at the indicated stages by S1 nuclease
mapping as described in Materials and Methods; the results are pre-
sented in lanes 1 to 6. The protected fragments were analyzed on a
10-cm-long 8% polyacrylamide–7 M urea gel. The results are repre-
sentative of analyses of oocytes from four different frogs. The results of
analysis of RNA from oocytes matured by treatment with progesterone
are shown in lane 7, and lane 8 shows the results of analysis of RNA
from Xenopus eggs. Lanes 9 and 10 show the results of analysis of
synthetic RNAs ending in the histone stem-loop and in the stem-loop
followed by 25 As, respectively. Lane 11 shows the results of analysis of
10 g of yeast tRNA. (D) Stage VI oocytes were incubated with
progesterone. At 1 h intervals, 20 oocytes were removed and pooled.
The oocytes were homogenized in buffer, and RNA was prepared from
80% of the homogenate. The rest of the homogenate (four oocytes)
was analyzed by sodium dodecyl sulfate (SDS)-gel electrophoresis, and
xSLBP2 was detected by Western blotting. The S1 analysis was done
using RNA from four oocytes. The percentages of histone mRNA
containing oligo(A) tails and the amounts of xSLBP2 (as determined
by Western blotting) are indicated, with 100% representing the levels
prior to addition of progesterone. At 7 h 70% of the oocytes had
matured (as determined by the appearance of the white spot at the
animal pole), and at 8 and 9 h all the selected oocytes had matured. No
oocytes had matured at 6 h.
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the histone stem-loop or in the stem-loop followed by 25 As were transcribed
with T7 RNA polymerase from appropriate DNA templates. The 184-nucleotide
(nt) PCR product contains 130 nt of histone mRNA and the 20-nt poly(A) tract
followed by 34 nt that had no complementarity to the histone xH2a mRNA. This
fragment was labeled at the 3 end with the Klenow fragment of DNA polymer-
ase I (New England Biolabs) and [-32P]dCTP. For the S1 analysis whose results
are shown in Fig. 1C and 2A, the plasmid encoding the xH2a gene was digested
with XmaI and labeled with the Klenow fragment of DNA polymerase I and
[-32P]dCTP. Hybridization was done at 56°C, and S1 digestion was performed
as previously described (10, 13) except that the digestion was carried out on ice
with 4 U of S1 nuclease to preserve the oligo(A-T) hybrids (35). The protected
fragments were resolved on a 10% polyacrylamide–7 M urea gel and detected by
autoradiography.
The S1 probe used to determine luciferase RNA levels (see Fig. 7) was
generated by linearization of the Luc-SL vector with DraII (which cleaves in the
luciferase coding region). The 3 end was labeled with the Klenow fragment of
DNA polymerase I and [-32P]dCTP. Total RNA was extracted (using TRIzol
reagent) (Invitrogen) from oocyte lysates, and 1 oocyte equivalent of total RNA
was hybridized to 5 ng of probe. Hybridization, S1 digestion, and detection were
performed as previously described (25).
For precise mapping of the 3 end of luciferase mRNA (see Fig. 7), the
terminal 230-nt sequence from the Luc-SL and Luc-SLA8 vector was amplified
by PCR and a unique HindIII site was introduced in the forward primer. These
amplified products were digested with HindIII and EcoRI and subcloned into
homologous sites in pGEM-3Zf to generate pGEM-Luc-SL and pGEM-Luc-
SLA8. The S1 probes used to determine the integrity of the 3 end of Luc-SL and
Luc-SLA8 were generated by linearization of pGEM-Luc-SL and pGEM-Luc-
SLA8 vectors with XbaI, which cuts 40 nt before the 3 end of the histone mRNA,
followed by labeling with the Klenow fragment of DNA polymerase I and [-
32P]dCTP. Hybridization was done at 56°C. S1 digestion was performed at 4°C as
described above.
Analysis of xSLBP proteins. The stem-loop probe and the conditions used for
the mobility shift assay were as previously described (25). Purification of the
anti-xSLBP antibodies and the conditions used for the Western blotting analysis
were as previously described (25, 33). Unlabeled and labeled RNAs ending in the
stem-loop or the stem-loop followed by oligo(A) for the mobility shift experi-
ments were transcribed (using T7 RNA polymerase) from appropriate templates.
In vitro transcription and translation. Transcription of capped and uncapped
luciferase constructs (as well as of xSLBP1, xSLBP2, MS2, and MS2-hSLBP
mRNAs) was performed as previously described (25). The synthesis of different
SLBPs in vitro and the analysis of translation of the luciferase reporter mRNAs
were done exactly as previously described, as were the protocols for microinjec-
tions, Western blotting, and luciferase assays (25).
RESULTS
Over 25 years ago, it was reported that histone mRNAs in
Xenopus oocytes, unlike histone mRNAs in other systems, con-
tain poly(A) tails, as determined on the basis of their ability to
bind to poly(dT) cellulose and as assayed by in vitro translation
(15, 22, 23). Several years later it became apparent that the A
tails were actually added onto the stem-loop sequence at the 3
end of histone mRNAs (2) and that the A tails were quite
short. Histone mRNAs cloned from cDNA libraries prepared
from Xenopus ovary mRNA primed with oligo(dT) contain
histone mRNAs encoding all five histone proteins with an A
tail following the stem-loop whose length varies but is likely
determined partly by the primers used to construct the library
(40; Z. F. Wang and W. F. Marzluff, unpublished data). When
we analyzed histone mRNAs by Northern blotting (even on
high-agarose-percentage gels), however, the histone mRNAs
from oocytes and eggs migrated identically (not shown). Since
histone mRNAs are only 500 nt long, poly(A) tails of 25 to 50
nt would have been readily apparent.
Oocyte histone mRNA has an A tail of 6 to 10 nt. To quan-
titatively analyze the 3 end of Xenopus histone mRNAs, we
developed an S1 nuclease protection assay that can measure
the length of the A tail on the 3 end of histone mRNA (Fig.
1A). We prepared a 3-labeled probe ending in the stem-loop
followed by 20 As and 34 additional nucleotides. The probe
was labeled at a site 130 nt from the end of the stem-loop,
allowing us to precisely resolve even very short oligo(A) tails.
For control mRNAs, we synthesized in vitro an mRNA ending
at the stem-loop and one ending at the stem-loop with a 25-A
extension. The probe containing 20 Ts will protect a 130-nt
fragment from the wild-type histone mRNA and a 150-nt frag-
ment from the mRNA ending in 20 As. A major challenge in
FIG. 2. Deadenylation and xSLBP2 degradation at oocyte matura-
tion does not require the nucleus. (A) Stage VI oocytes collected from
a single frog were divided into two groups. One group (W) was incu-
bated in OR-2 buffer with () progesterone (Prog) for 12 h (lane 3) or
without () progesterone (lane 2). The second group of oocytes was
enucleated (C); half of these oocytes were incubated in buffer (lane 4)
without progesterone and the other half were treated with progester-
one for 12 h (lane 5). A total of 20 oocytes were randomly selected
from each of the four sets of oocytes, and RNAs were prepared. A
total of 85% of the oocytes that had been treated with progesterone
had matured after 12 h. One oocyte equivalent of RNA was analyzed
by S1 nuclease mapping as described for Fig. 1C. Lane 1 shows the
analysis of one egg equivalent of RNA from Xenopus eggs. (B) Stage
VI oocytes from a single frog were treated as described for panel A. A
total of 20 oocytes from each treatment were randomly selected after
10 h (lanes 1, 3, 5, and 7) or 24 h (lanes 2, 4, 6, and 8) of incubation with
or without progesterone. Total cell protein was prepared and resolved
by gel electrophoresis, and SLBP2 was detected by Western blotting.
The oocytes in lanes 3, 4, 7, and 8 were enucleated, while the oocytes
in lanes 1, 2, 5, and 6 were intact. The band labeled with a star
represents a cross-reacting protein that remains constant during oocyte
maturation and serves as an internal control.
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the S1 mapping experiments is maintaining the integrity of the
oligo(A-T) hybrids at the 3 end of the mRNA during the
experiment. To enhance annealing of the oligo(A-T) sequence,
we used the minimal amount of enzyme necessary to degrade
the free probe and performed the S1 digestions on ice (35). For
each set of S1 nuclease assays we included the two control
mRNAs. This approach allowed us to control for the loss of the
A-T tail by S1 digestion of the relatively unstable oligo(A-T)
hybrid, which occurred to different extents among the sets of
samples.
We used this assay to determine the 3 end of the Xenopus
histone H2a mRNA during oogenesis. The control mRNA
ending at the stem-loop protected a 130-nt fragment as ex-
pected, while the control mRNA ending in 25 As protected a
major fragment of 150 nt (protecting the 20 Ts in the probe;
Fig. 1B, lanes 3 and 4, respectively). The polyadenylated con-
trol mRNA displays a distribution of slightly smaller fragments
as well as a small amount of the 130-nt protected fragment
(Fig. 1B, lane 4). The 130-nt fragment could result either from
“breathing” of the A-T hybrid, which allows the S1 nuclease to
cleave the probe in the A stretch (resulting in subsequent
complete removal of the A-T hybrid region), or from a small
amount of the control mRNA that was not adenylated. We
assayed total RNA from stage III and stage VI oocytes and
matured oocytes. The oocyte histone mRNAs protected frag-
ments longer than 130 nt. The most abundant fragments were
5 to 8 nt longer than those seen with the mature histone
mRNA, with protected fragments up to 10 to 11 nt in length
detected. Only a small proportion of the protected fragments
were 130 nt, consistent with the great majority (if not all) of the
mRNA ending in an oligo(A) tail (Fig. 1B, lanes 5 and 6). In
contrast, RNA from in vitro-matured oocytes protected a ma-
jor fragment of 130 nt, similar to the results seen with the
standard synthetic histone mRNA (Fig. 1B, lane 7). These
results are in general agreement with the results of Ballantine
and Woodland (2).
We determined the state of the 3 end of the Xenopus his-
tone mRNAs during oogenesis and early development. In
stage I oocytes, most of the histone mRNAs do not contain A
tails (Fig. 1C, lane 1). The mRNA from stage II oocytes was
partially adenylated. In stages III and VI of oogenesis, the
great majority of the histone mRNAs contained a short A tail
(Fig. 1C, lanes 3 to 6). Since RNAs from the same number of
oocytes were analyzed for each lane, this assay allows us to
determine the relative amounts of histone mRNAs in different
stages of oogenesis. Note that as is true for most other mater-
nal mRNAs (7) and as previously reported for histone mRNAs
(38), most of the histone mRNA accumulates very early in
oogenesis and the steady-state level of histone mRNA remains
constant after stage III of oogenesis.
Different stage II oocyte preparations gave different propor-
tions of adenylated histone mRNAs (the distinction between
oocyte stages is somewhat subjective during the sorting of the
oocytes), but all preparations of stage I oocytes contained less
histone mRNA with little or no adenylated mRNA. We con-
clude that in very early oogenesis (stages I and II), most of the
histone mRNAs do not contain A tails and that by stage III the
great majority (if not all) of the histone mRNAs contain A
tails.
To determine whether the A tails were lost during oocyte
maturation, we treated stage VI oocytes with progesterone and
compared the histone mRNA levels in stage VI oocytes to
those of oocytes which had matured after progesterone treat-
ment (Fig. 1C, lanes 6 and 7). We also analyzed the histone
mRNA from eggs in a parallel assay (Fig. 1C, lane 8). The
histone mRNA from oocytes matured in vitro with progester-
one (as well as the histone mRNA from eggs) was not adeny-
lated. Therefore, treatment of the oocytes with progesterone
recapitulated the loss of the oligo(A) tails from histone
mRNA.
xSLBP2, which inhibits histone mRNA translation, is also
degraded during oocyte maturation (33). To determine the
relative timings of these two changes, we analyzed the amounts
of xSLBP2 by Western blotting and the proportion of histone
mRNAs containing the oligo(A) tails by S1 nuclease assay at
1-h intervals after progesterone treatment. The removal of the
oligo(A) tails and the destruction of xSLBP2 occurred in par-
allel (Fig. 1D). This assay has limited temporal resolution, due
to the lack of precise synchrony with which oocytes respond to
progesterone and to the absence of phenotypic markers for the
progression of maturation. Although the removal of the oli-
go(A) tails and the destruction of xSLBP2 could not be tem-
porally separated, both had occurred extensively prior to the
appearance of the white spot on the animal pole that is indic-
ative of germinal vesicle breakdown and completion of oocyte
maturation.
Deadenylation of histone mRNA and degradation of
xSLBP2 at maturation can occur in the absence of the nucleus.
Messages that lack a cytoplasmic polyadenylation element
(CPE) undergo default deadenylation at maturation, and their
translational activity is inhibited (8, 31). An mRNA deadeny-
lase called DAN has been purified from Xenopus oocytes, and
there is a human orthologue called PARN. Removal of the
nucleus or injection of antibodies against DAN (PARN) in-
hibits default deadenylation (14). To test whether removal of
the histone mRNA oligo(A) tract at maturation requires the
nucleus (like default deadenylation of non-CPE-containing
mRNAs), enucleated oocytes were treated with progesterone
to induce maturation. When enucleated oocytes were treated
with progesterone, the histone mRNAs lost their oligo(A) tract
to the same extent as whole oocytes treated with progesterone
(Fig. 2A; compare lanes 3 and 5).
We also tested whether enucleated oocytes treated with pro-
gesterone degraded xSLBP2. Treatment of stage VI oocytes
with progesterone resulted in a loss of xSLBP2 as analyzed by
Western blotting (Fig. 2B, lanes 5 and 6). Identical results were
obtained when the oocytes were enucleated prior to treatment
with progesterone (Fig. 2B, lanes 7 and 8). We conclude that
removal of the histone mRNA oligo(A) tail and the degrada-
tion of xSLBP2 can be mediated solely by cytoplasmic factors
and is not dependent on germinal vesicle breakdown.
The presence of the oligo(A) tail does not affect binding of
either xSLBP. One function of the oligo(A) tail could be to
help determine which xSLBP is associated with the histone
mRNA. A second possibility is that another (or multiple) fac-
tor(s) could stably associate with the oligo(A) tail. Note that
these tails are not long enough to be bound by the poly(A)
binding protein (PABP), so it is unlikely that PABP binds to
the oocyte histone mRNA via the poly(A) tract (24). To de-
termine whether the two xSLBPs show different relative affin-
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FIG. 3. xSLBP1 and xSLBP2 bind equally well to the stem-loop and the oligoadenylated stem-loop. (A) Extracts from stage I (top panel) or
stage VI (bottom panel) oocytes were incubated with the stem-loop (SL) probe (lanes 1 to 11) or the radiolabeled oligoadenylated stem-loop probe
(lanes 12 to 22). Increasing amounts of competitor stem-loop (0.1 to 10 ng; lanes 2 to 6 and lanes 13 to 17) or oligoadenylated stem-loop (0.1 to
10 ng; lanes 7 to 11 and lanes 18 to 22) were mixed with the probe prior to addition of the oocyte lysate. Complexes were resolved by electrophoresis
on 8% polyacrylamide gels under native conditions and detected by autoradiography. The positions of the complexes with xSLBP1 (x1) and xSLBP2
(x2) are indicated. Lanes 1 and 12 were analyzed without an added competitor. (B) xSLBP1 and xSLBP2 were synthesized in reticulocyte lysates
in the presence of [35S]methionine, and the amounts of each protein were estimated by autoradiography of the in vitro-synthesized proteins. The
amounts of xSLBP1 and xSLBP2 required to completely shift the stem-loop probe or the SLA8 probe were determined. Mobility shift assays were
performed with () or without () radiolabeled SLA8 probe (lanes 1 to 6) or the stem-loop probe (lanes 7 to 12). The same amount of xSLBP1
or xSLBP2 was incubated with the stem-loop probe (lanes 1, 3, 7, and 9). After incubation for 5 min at 4°C, a 10-fold excess (10x) of the other
xSLBP was added (lanes 2, 4, 8, and 10) and the reaction mixture was incubated for 60 min prior to analysis. For lanes 5, 6, 11, and 12, the two
proteins were mixed prior to the addition of the probe (premix).
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ities for the histone stem-loop and the stem-loop with an oli-
go(A) tail, we performed mobility shift assays. We used
extracts from stage I oocytes, which primarily form complexes
containing xSLBP2 (33), and extracts from stage VI oocytes,
which form complexes containing both xSLBP1 and xSLBP2,
with xSLBP1 complexes being the more abundant species. We
incubated each extract with either a radiolabeled stem-loop
probe or with the stem-loop with 8 As (SLA8) attached. We
then tested the ability of stem-loop and SLA8 unlabeled RNAs
to compete for the binding of each xSLBP. Note that these
assays are done using oocyte extracts, so any modifications of
the xSLBPs that could alter their affinity for the stem-loop
(which might occur at different stages of oogenesis) are likely
to be retained. The two SLBPs bound the two probes with
similar affinities, and the stem-loop and SLA8 unlabeled RNAs
were equally effective in competing for the binding to either
the SL or the SLA8 probe (Fig. 3A). Similar results were
previously reported for the wild-type probe when the proteins
were expressed in reticulocyte lysates (13).
We also tested the ability of the SLA25 probe to bind to
proteins in the oocyte extracts. This probe, which contains 25
As after the stem-loop, can be bound by PABP. We observed
complexes which resulted from both PABP and SLBP binding
to the same probe (data not shown). Thus, the A8 tail is not
long enough to bind PABP.
The SLBPs do not rapidly exchange in vitro. A striking
finding in the previous work of Wang et al. was that xSLBP1
was bound to histone mRNA early in oogenesis whereas
xSLBP2 was bound to the histone mRNA late in oogenesis
(33). When the amounts of active xSLBPs are determined by
mobility shift assays, however, xSLBP2 is the major SLBP early
in oogenesis and xSLBP1 is the major SLBP late in oogenesis
FIG. 4. xSLBP1 stimulates the translation of the Luc-SL and Luc-SLA8 mRNAs in vitro. (A) The seven reporter mRNAs used in the various
translation experiments are represented at the top. A diagram of the in vitro translation assay (taken from reference 25) is shown in the lower
panel. SLBP1 or SLBP2 was synthesized from capped synthetic mRNA in a reticulocyte lysate in the presence of [35S]methionine. Aliquots of
lysates containing xSLBP1 or xSLBP2 were added to fresh lysate together with luciferase reporter mRNA and an uncapped polyadenylated CAT
mRNA and incubated for 90 min. (B) The uncapped Luc-TL (lanes 1 and 4), Luc-SL (lanes 2 and 5), or Luc-SLA8 (lanes 3 and 6) mRNAs were
added to reticulocyte lysates containing xSLBP1 (lanes 1 to 3) or xSLBP2 (lanes 4 to 6) together with uncapped polyadenylated CAT mRNA. The
translation products were resolved by SDS-polyacrylamide gel electrophoresis and detected by autoradiography. There was a slight increase in the
translation of the Luc-TL mRNA in the presence of xSLBP2 in the experiment whose results are shown, but this was not observed in multiple other
experiments; in those experiments, there was essentially no effect seen on translation of either the Luc-TL or Luc-SL mRNAs by SLBP2 in the
reticulocyte lysate (25). SL, stem-loop. (C) The reaction mixtures described for panel B were analyzed for luciferase activity; the activity levels are
expressed relative to the Luc-TL mRNA levels.
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(33). Since it is possible that one function of the poly(A) tail is
to alter the exchangeability of the SLBPs, we tested whether
the xSLBPs would interchange in vitro on either the wild-type
or the oligo(A) stem-loop probe.
We synthesized the xSLBPs in vitro using rabbit reticulocyte
lysates and labeled the proteins with [35S]methionine to allow
us to estimate the amount of protein (there is no mammalian
SLBP in reticulocyte lysates; see reference 34). We incubated
the probe with an excess of one of the SLBPs under conditions
in which the entire radiolabeled probe formed a complex with
an SLBP after incubation for 5 min at 4°C. An approximately
10-fold excess of the second SLBP was then added to the
extract and incubated for an additional 60 min on ice. As
controls the proteins were mixed together prior to addition of
the probe.
When we formed a complex with xSLBP1 on either the
SLA8 (Fig. 3B, lane 1) or the stem-loop (Fig. 3B, lane 7)
probe, all of the probe formed a single complex. When we
mixed an excess of xSLBP2 with xSLBP1 prior to addition to
the probe, about 90% of the complexes formed contained
xSLBP2 with both probes (Fig. 3B, lanes 5 and 11). However,
when the same amount of excess xSLBP2 was added after
formation of the complex with xSLBP1, there was a less than
10% exchange of the proteins in 60 min at 4°C (Fig. 3B, lanes
2 and 8). When the experiment was reversed (forming the
complexes on xSLBP2 first), the addition of excess xSLBP1
FIG. 5. xSLBP1 does not activate translation of Luc-SLA8 mRNA in vivo. (A) A schematic of the assay is shown (25). Oocytes were injected
with a synthetic mRNA encoding an SLBP protein and were injected 16 h later with a firefly luciferase reporter mRNA together with a Renilla
luciferase internal control ending in the stem-loop. A total of 20 oocytes from each time point were pooled. The ratio of the firefly and Renilla
luciferase activity levels was used to determine the relative translational activity levels of the various reporter mRNAs. The activity of the Luc-TL
mRNA was set at 1. The same lysates were assayed for xSLBP proteins by Western blotting and for luciferase RNAs by S1 nuclease mapping.
(B) Oocytes were injected with buffer, xSLBP1 mRNA, or xSLBP2 mRNA and were injected 16 h later with Luc-TL, Luc-SL, or Luc-SLA8 and
the Renilla luciferase internal control. Oocytes were harvested 8, 16, or 24 h later, and the luciferase activity levels were determined. The luciferase
activity was normalized to the Renilla luciferase level at each time point, and the average and standard deviations of the relative expression levels
are shown. There was a steady increase in the absolute amount of luciferase activity during the incubation, and the absolute luciferase activity level
was about 50% higher in the 24-h than in the 16-h samples. (C) The amounts of xSLBP2 (left panels) or xSLBP1 (right panels) in the 16- and 24-h
extracts were determined by Western blotting. (Left panels) Lanes 1 and 2 show endogenous xSLBP2 levels in oocytes injected with buffer and
oocytes matured with progesterone, respectively. A lighter exposure of the gel region is shown in the bottom panel. The star indicates a
cross-reacting protein, which serves as an internal control (Fig. 2B). (Right panels) All of the samples in lanes 9 to 14 come from the same gel and
were exposed for the same time. The exogenous xSLBP2 has a slightly faster mobility than the endogenous xSLBP2 due to variations among the
results for different frogs (25). SL, stem-loop.
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resulted in partial exchange during the 60-min incubation. Par-
tial exchange was observed on both probes (Fig. 3B, lanes 4
and 10). When the proteins were premixed in the same
amounts used in the exchange experiments, the xSLBP1 com-
plex was the only complex detected with either probe (Fig. 3B,
lanes 6 and 12). These results demonstrate that the proteins do
not exchange rapidly, in agreement with previous results that
the RNA does not rapidly dissociate from SLBP (37). The
presence of the oligo(A) sequence did not affect the exchange
of the SLBPs in vitro.
Effect of the oligo(A) tract on translation in vitro. We have
previously shown that xSLBP1 actively supports translation of
a luciferase reporter mRNA ending in a stem-loop (both in
reticulocyte lysates and in stage VI oocytes) whereas xSLBP2
does not (25). An MS2-SLBP fusion protein will also stimulate
translation of luciferase reporter mRNAs that end in the his-
tone stem-loop or the MS2 binding site (25). To determine
whether the short A tail had any effect on the translation of the
reporter mRNA ending in the stem-loop, we constructed a
luciferase mRNA that ended in a stem-loop followed by 8 As
(Luc-SLA8). As controls we constructed reporter mRNAs that
ended in 8 Cs (Luc-SLC8) or in a random 8-nt sequence
(Luc-SLN8). We also used mRNAs ending in the MS2 binding
site (Luc-MS2) or in the MS2 site followed by 8 As (Luc-
MS2A8). The constructs are shown in Fig. 4A.
In the in vitro assay, either xSLBP1 or xSLBP2 is first syn-
thesized in a reticulocyte lysate from synthetic capped mRNA.
Lysate containing the SLBP is then mixed with fresh lysate in
the presence of an uncapped luciferase reporter mRNA and a
competitor uncapped polyadenylated chloramphenicol acetyl-
transferase (CAT) mRNA (Fig. 4A). The CAT protein pro-
duced from this mRNA serves as an internal standard, and the
luciferase expression is normalized to the expression of CAT
protein within each experiment. This assay measures the ability
of the reporter mRNA to compete effectively for initiation
factors in the reticulocyte lysate. Previously we had shown that
xSLBP1, but not xSLBP2, stimulates translation of the reporter
Luc-SL mRNA but not of the Luc-TL mRNA containing a
GCAA TL instead of the UUUC loop (25).
We compared the effect of the presence of xSLBP1 and
xSLBP2 on translation of the Luc-SL, Luc-SLA8, and Luc-TL
mRNAs in vitro. When xSLBP1 was synthesized in the lysate
prior to the addition of the luciferase mRNAs, there was a six-
to eightfold increase in the translation efficiency of both the
Luc-SL and Luc-SLA8 mRNAs (Fig. 4B, lanes 2 and 3, and
Fig. 4C) compared to the results seen with translation of
Luc-TL mRNA (Fig. 4B, lane 1, and Fig. 4C), as determined
both by luciferase assay and by autoradiography of the lucif-
erase protein. Addition of a lysate containing xSLBP2 did not
affect translation of any of the reporter mRNAs (Fig. 4B, lanes
4 to 6, and Fig. 4C). We conclude that the oligo(A) tail does
not affect the ability of xSLBP1 to activate translation of the
Luc-SLA8 mRNA in the reticulocyte lysate.
The oligo(A) tail reduces activation of translation of the
Luc-SLA8 mRNA in Xenopus oocytes. To assay translation of
the reporter mRNAs in vivo (Fig. 5A) (25), we first injected a
synthetic mRNA encoding an SLBP protein into stage VI
oocytes. At 16 h later we injected equal amounts of a capped
FIG. 6. Failure to activate translation is specific for the oligo(A) tail. Oocytes were injected with either xSLBP1 mRNA or buffer. At 16 h later
they were injected with one of the reporter mRNAs shown in Fig. 4A. After incubation for an additional 16 h, oocytes were harvested and luciferase
activity levels were measured (A). The averages of the results of two independent experiments (with the standard deviations indicated) are shown.
A portion of the extract was also analyzed for xSLBP1 levels by Western blotting in oocytes injected with buffer (panel B, lane 1) or with the
indicated constructs (panel B, lanes 2 to 6). SL, stem-loop.
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synthetic firefly luciferase mRNA (Luc-test) together with an
internal standard capped Renilla luciferase mRNA ending in
the histone stem-loop (R-Luc-SL). At different times after
injection of the reporter mRNAs we harvested the oocytes and
measured the firefly and Renilla luciferase activity levels. Using
this assay we previously showed that xSLBP1 (but not xSLBP2)
activates translation of the Luc-SL mRNA in vivo; the in vitro
and in vivo assays gave essentially identical results (25).
In the first experiments we determined the levels of lucif-
erase activity at 8, 16, and 24 h after injection of the synthetic
luciferase mRNAs containing different 3 ends. In oocytes in-
jected with buffer (Fig. 5B), there was a two- to threefold
increase in luciferase activity from the Luc-SL mRNA (com-
pared to the results seen with Luc-TL) due to the activity of
endogenous xSLBP1 in the oocytes (25). However, the Luc-
SLA8 was translated at levels very similar to those of the
Luc-TL mRNA. When xSLBP1 mRNA was injected prior to
injection of the luciferase mRNA, there was an 8- to 15-fold
increase in luciferase activity from the Luc-SL mRNA after
injection of the reporter mRNAs but only a 2- to 3-fold in-
crease in luciferase activity from the Luc-SLA8 mRNA com-
pared with the results seen with Luc-TL mRNA (Fig. 5B). The
Luc-SL, Luc-SLA8, and Luc-TL synthetic mRNAs exhibited
similar levels of activity after overexpression of xSLBP2 (Fig.
5B), since the excess xSLBP2 prevents activation of translation
by the endogenous xSLBP1 (25). The relative expression levels
of luciferase from the different mRNAs at 8, 16, and 24 h after
injection of the reporter mRNAs were similar.
We measured (by Western blotting) the amount of xSLBP1
and xSLBP2 present in the oocytes injected with the synthetic
SLBP mRNAs. The oocytes injected with the xSLBP2 or
xSLBP1 mRNA expressed a large excess of the xSLBP both 16
and 24 h after injection of the reporter mRNAs (Fig. 5C)
compared with the oocytes injected with buffer (Fig. 5C, lane 1,
lanes 9 to 14, bottom panels).
We repeated this experiment with an independent set of
oocytes. As additional controls we also used reporter mRNAs
ending in a stem-loop followed by 8 Cs (Luc-SLC8) or by a
random nucleotide sequence (Luc-SLN8; Fig. 4A). The oo-
cytes were harvested 24 h after injecting these reporter
mRNAs. In these oocytes, expression of exogenous xSLBP1
results in an approximately sixfold increase in translation of the
Luc-SL reporter mRNA compared to the results seen with the
Luc-TL mRNA. In contrast, translation of the Luc-SLA8
mRNA was stimulated only twofold in the oocytes expressing
xSLBP1 (Fig. 6A). However, the Luc-SLC8 and Luc-SLN8
RNAs were translated with only slightly reduced efficiency
compared with the Luc-SL RNA. Expression of xSLBP2 in the
oocytes prior to injection of the reporter mRNAs again re-
duced translation of the Luc-SL mRNA compared to the re-
FIG. 7. The different reporter mRNAs are equally stable, and the A8 tail is not lost after injection. (A) Oocytes were injected with buffer (lanes
1 to 3 and 10), xSLBP1 mRNA (lanes 4 to 6), or xSLBP2 mRNA (lanes 7 to 9) and were injected 16 h later with Luc-SL (lanes 1, 4, and 7),
Luc-SLA8 (lanes 2, 5, and 8), Luc-TL mRNA (lanes 3, 6, and 9), or buffer (lane 10). RNA was prepared 16 h later, and one oocyte equivalent of
RNA was analyzed by S1 nuclease mapping, using the Luc-SL gene labeled at the 3 end of a restriction enzyme site in the luciferase coding region
as described in Materials and Methods. These samples are from the collection of oocytes used as described for Fig. 5B and C. The probe protects
the same fragment from the Luc-SL and Luc-SLA8 mRNA, which maps to the stem-loop (SL), and a 15-nt-shorter fragment from the Luc-TL
mRNA, which differs in the loop. Since the probe is end labeled, the intensity of the band is proportional to the amount of mRNA in the sample.
(B) RNA samples (used as described for panel A) from oocytes injected first with xSLBP1 mRNA and then with either Luc-SL (lane 1), Luc-SLA8
(lane 2), or buffer (lane 3) were analyzed using a probe which contains the SLA8 tail, with the end of the stem-loop 40 nt from the labeled end.
The protected fragments were analyzed on a 10% polyacrylamide–7 M urea gel. The positions of the fragments ending at the stem-loop (40 nt)
and the SLA8 tail (48 nt) are indicated.
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sults seen with injection of buffer, and all five reporter mRNAs
were translated to the same extent (Fig. 6A). In these oocytes
injected with buffer there was a twofold activation of the
Luc-SL (compared to the results seen with Luc-TL mRNA
reporter) due to the presence of endogenous xSLBP1 in the
oocyte. There was no activation of the Luc-SLA8 mRNA; this
RNA was translated to the same extent as the Luc-TL mRNA
(Fig. 6A), although Luc-SLC8 and Luc-SLN8 were both trans-
lated at rates similar to those seen with the Luc-SL RNA. The
levels of the exogenous proteins were the same in all extracts
regardless of which reporter mRNAs had been injected (Fig.
6B). We also tested the ability of all five of these capped RNA
preparations to translate in the rabbit reticulocyte lysate, and
they were all equally active (not shown, but see Fig. 8).
The reporter mRNAs are stable and the 3 ends remain
intact after injection. To rule out the possibility that these
results were due to different levels of stability of the reporter
mRNAs, we performed S1 protection assays using total RNA
from oocytes harvested 16 h after luciferase mRNA injection.
Two different probes were used in the S1 nuclease assays. We
used a 3 end-labeled DNA probe that was complementary to
the Luc-SL construct to measure the total amount of each of
the reporter mRNAs. This probe hybridizes to all the lucif-
erase mRNAs, and the protected fragments are identical for
the Luc-SL and Luc-SLA8 mRNAs and 15 nt shorter for the
Luc-TL mRNA (which diverges from the Luc-SL mRNA at the
start of the loop) (Fig. 7A). Since there is a single radioactive
phosphate in the probe, the intensity of the protected fragment
is directly proportional to the concentration of the mRNA.
Similar amounts of all three mRNAs were present in the oo-
cytes harvested 16 h after injection of the reporter mRNAs,
regardless of which xSLBP was expressed in the oocytes (Fig.
7A). These data demonstrate that the stability of the injected
luciferase mRNA is not affected by the nature of its 3 end or
by the amount of either xSLBP. Thus, the differences in trans-
FIG. 8. The MS2-hSLBP protein activates translation of the Luc-
MS2A8 mRNA but not the Luc-SLA8 mRNA. (A) Capped luciferase
reporter mRNAs (Luc-TL, lane 1; Luc-SL, lane 2; Luc-SLA8, lane 3;
Luc-pA, lane 4; Luc-MS2, lane 5; Luc-MS2A8, lane 6) were mixed with
equal amounts of the R-Luc-SL mRNA and translated in a reticulocyte
lysate in the presence of [35S]methionine. The products were resolved
by SDS-polyacrylamide gel electrophoresis and detected by autora-
diography. The constructs are those shown in Fig. 4A (except for
Luc-pA, which contains a 50-nt poly(A) tail) (25). SL, stem-loop;
F/Luc, firefly luciferase; R/Luc, Renilla luciferase. (B) Xenopus oocytes
were injected with buffer or with synthetic mRNAs encoding hSLBP, a
MS2-hSLBP fusion protein, or the MS2 protein. At 16 h later the
reporter mRNAs (Luc-TL, Luc-SL, Luc-SLA8, Luc-SLMS2, and Luc-
MS2A8) analyzed as described for panel A were injected, and the
oocytes were incubated for an additional 16 h. The oocytes were
harvested, and luciferase activity levels were determined, with the
activity of Luc-TL set at 1. The averages of the results of two inde-
pendent experiments using different frogs are shown. (C) The extracts
(described for panel B) from oocytes containing the reporter mRNAs
indicated at the top of each lane and expressing either human SLBP
(lanes 1 to 5) or the MS2-hSLBP fusion protein (lanes 6 to 10) were
incubated with the radiolabeled stem-loop probe, and the complexes
were resolved by native gel electrophoresis. The positions of the en-
dogenous xSLBP1 and xSLBP2 complexes are indicated by x1 and x2.
Because of the large size of the MS2-hSLBP fusion protein, the com-
plex migrates near the top of the gel.
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lation efficiency levels are not due to differences in mRNA
stability.
The probe used for the S1 protection assay in Fig. 7A would
not detect any change that might occur on the oligo(A) tail of
the Luc-SLA8 mRNA, since it extended only to the end of the
stem-loop. To verify the integrity of the 3 end of the reporter
mRNAs 16 h after injection, we designed a short probe that
contained the 3 end of the Luc-SLA8 mRNA (Fig. 7B). To
facilitate resolution of the small changes in length, this probe
protected only 40 nt prior to the end of the stem-loop. We
analyzed the RNA from oocytes that overexpressed xSLBP1
and that were injected with Luc-SL and Luc-SLA8 mRNAs. At
16 h after injection of the reporter mRNAs, the 3 end of the
Luc-SLA8 mRNA still contained the eight adenosines (Fig.
7B, lane 2) whereas the Luc-SL mRNA did not have any
adenosines added to the 3 end (Fig. 7B, lane 1). These pro-
tected fragments were absent from oocytes that did not have
reporter mRNA injected (Fig. 7B, lane 3). Since the same
probe was used in lanes 1 to 3, this experiment also confirms
that the amounts of the Luc-SL and Luc-SLA8 mRNA were
similar in the injected oocytes.
Translation repression in stage VI Xenopus oocytes requires
the stem-loop and the oligo(A) tail. Previously we showed that
an MS2-SLBP fusion protein can activate translation of a re-
porter mRNA that ends in an MS2 binding site as well as of an
RNA that ends in the stem-loop (25). We compared the ability
of the MS2-SLBP fusion protein to activate translation of re-
porter mRNAs that end either in the MS2 site or the MS2 site
followed by 8As (Luc-MS2A8) with its ability to activate trans-
lation of the Luc-SL and Luc-SLA8 mRNAs. We synthesized
five capped reporter mRNAs (encoding firefly luciferase) with
different 3 ends and mixed them with the internal control
mRNA (encoding Renilla luciferase) ending in the stem-loop.
All of these mRNAs were translated to the same extent in the
reticulocyte lysate in the absence of SLBP (Fig. 8A).
These same RNA preparations were injected into Xenopus
oocytes expressing either human SLBP, MS2 protein, or the
MS2-SLBP fusion protein (Fig. 8B). Both the human SLBP
and the MS2-SLBP fusion protein were overexpressed relative
to the endogenous SLBPs, as measured by the mobility shift
assay (Fig. 8C). The human SLBP activated translation of the
Luc-SL mRNA but not that of the Luc-SLA8 mRNA or that of
the mRNAs ending in the MS2 binding site. We tested whether
placing an oligo(A) tail on the reporter mRNA ending in the
MS2 site would affect activation of translation by the MS2-
SLBP fusion protein. The MS2-SLBP fusion protein activated
the levels of translation of the Luc-MS2 and the Luc-SL mR-
NAs to the same extent. However, the MS2-SLBP protein gave
different results with the mRNAs that ended in 8 As. Like the
hSLBP, the MS2-SLBP did not activate translation of the Luc-
SLA8 mRNA. However, the MS2-SLBP did activate transla-
tion of the Luc-MS2A8 mRNA significantly more than it sup-
ported translation of the Luc-SLA8 mRNA. This result
suggests that the inactivation of the Luc-SLA8 mRNA requires
that the adenosines be attached to the histone stem-loop and
suggests that there is a direct interaction between the stem-
loop, an SLBP, and the eight adenosines and any associated
factor(s) required for translational repression.
DISCUSSION
During oogenesis and early embryogenesis most of the reg-
ulation of gene activity occurs at the level of translation. A
number of maternal mRNAs are stored in the Xenopus oocyte
in an inactive form, and their translation is ultimately con-
trolled in a precise temporal and spatial pattern (11) during
oocyte maturation and early embryogenesis. These mRNAs
include the mRNAs encoding essential proteins for cell cycle
progression (3, 29). Histone proteins are critical components
of the chromosome, and their assembly into newly replicating
chromatin must occur appropriately during each S phase.
There is not only storage of histone mRNA during oogenesis
but also storage of histone proteins complexed with specific
histone binding proteins, nucleoplasmin, and N1/N2 (5). Like
the histone mRNAs, most of the histone protein stored in the
oocyte is also synthesized prior to stage III, after which time
the histone mRNA is translationally inactive (39). Translation
of histone mRNAs is reactivated at oocyte maturation (1).
Translational regulation of histone mRNA. A major com-
ponent of the regulation of translation of histone mRNA dur-
ing Xenopus oogenesis is the presence of xSLBP1 and xSLBP2,
two different proteins that bind the 3 end of these mRNAs
(33). xSLBP1 stimulates translation in vivo and in vitro of
reporter mRNAs that end with the 3 end of histone mRNA
(25) and likely is required for efficient translation of histone
mRNAs in vivo. xSLBP2, which is oocyte specific, does not
support translation of histone mRNA and probably is involved
in translational repression of histone mRNA.
Oocyte histone mRNAs differ from other histone mRNAs in
that there is an oligo(A) tail added to their 3 end. This tail is
too short to bind a molecule of PABP (24). The oligo(A) tail
is added to the histone mRNA early in oogenesis and is asso-
ciated with the translationally inactive histone mRNA. In vitro
both xSLBP1 and xSLBP2 bind to the oligoadenylated histone
mRNAs with similar affinities, and these proteins do not
readily exchange. However, in vivo it is likely that other factors
bind to the oligoadenylated 3 end and it is possible that these
factors interact with xSLBP2. Other than xSLBP2, the protein
components of the stored histone mRNA are not known.
When stage VI oocytes were matured in vitro, we did not
observe degradation of exogenously expressed xSLBP2
whether or not it was bound to histone mRNP or detect re-
moval of the oligo(A) tail from injected in vitro-synthesized
histone mRNAs (unpublished results). These results suggest
that the xSLBP2/histone mRNA complex must be stored in a
specific compartment or particle in the oocyte, which allows
degradation of xSLBP2 and removal of the oligo(A) tail after
oocyte activation. Exogenous xSLBP2 and/or histone mRNA
may not be sequestered properly in the oocyte for degradation
and deadenylation to occur at maturation.
A second possible function of the oligo(A) tail is to stabilize
the histone mRNA for the long-term storage during oogenesis.
We have recently characterized a mammalian 3 exonuclease
that specifically binds the 3 end of histone mRNA (6), and this
exonuclease would not bind to the oligoadenylated form of
histone mRNA.
Strikingly, the oligoadenylated histone mRNA is not effi-
ciently translated in Xenopus oocytes (even in the presence of
a large excess of xSLBP1). This is not a result of a lower affinity
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of the xSLBP1 for the oligoadenylated histone mRNA, since
xSLBP1 binds well to the oligoadenylated stem-loop and is
equally active in stimulating translation of wild-type histone
mRNA and oligoadenylated histone mRNAs in a reticulocyte
lysate. The minimal xSLBP1 protein required for translation
activation (a deletion of the first 68 amino acids and of the
C-terminal domain; see reference 25) was also inactive in
translation of the oligoadenylated histone mRNAs (data not
shown). This result strongly suggests that there are oocyte-
specific factors that interact with the oligoadenylated histone
mRNA, inhibiting its translation by preventing xSLBP1 from
interacting with its target in the initiation machinery. Activa-
tion of histone mRNA translation when oocytes are treated
with progesterone requires both the removal of the xSLBP2
from the stored histone mRNA and the removal of the oli-
go(A) tail. Both of these events occur in enucleated oocytes
that have been treated with progesterone. It is likely that a
result of progesterone treatment is activation of the pathway
leading to both xSLBP2 removal from the histone mRNA and
destruction of xSLBP2 (as well as removal of the oligo(A) tail
from the histone mRNA). It is reasonable to suspect that these
events are mediated by the same signal.
Translation regulation of other mRNAs. Extensive progress
has been made recently in understanding the mechanism of
translational regulation of the c-mos mRNA required for ini-
tiation of oocyte maturation (26, 28) as well as the regulation
of translation of cyclin B mRNA (3, 29). Translation of these
polyadenylated mRNAs is regulated by alterations in the
length of the poly(A) tail and by proteins that interact with the
untranslated regions (4, 20). c-mos mRNA is one of the earliest
mRNAs whose translation is altered in response to progester-
one treatment (26). Activation of c-mos translation requires
the Eg2 kinase which is activated by treatment with progester-
one (19, 20). c-mos translation activation also requires the CPE
located in the 3 untranslated region of c-mos mRNA. CPEB,
the protein that binds the CPE, is phosphorylated upon pro-
gesterone stimulation. Before oocyte maturation CPEB is
linked to eIF-4E, the cap-binding protein, via the maskin pro-
tein. Maskin prevents the assembly of the translation preini-
tiation complex by impeding the interaction between eIF-4E
and eIF-4G. Phosphorylation of CPEB in response to proges-
terone stimulation causes the release of CPEB-bound maskin
from eIF-4E and promotes the recruitment of CPSF to c-mos
mRNA (27). CPSF then recruits a poly(A) polymerase, possi-
bly a novel poly(A) polymerase (32), that lengthens the
poly(A) tail. These changes in translation of polyadenylated
mRNAs important for cell-cycle regulation are occurring at the
same time as the changes in the histone mRNA.
A second consequence of treatment of oocytes with proges-
terone is the shortening of the poly(A) tail on some of the
oocyte mRNAs, resulting in translation arrest (8). The short-
ening of the poly(A) tail requires the presence of PARN, a 3
exonuclease specific for poly(A) tails (14). It has been reported
that shortening of the poly(A) tails on oocyte mRNAs requires
the breakdown of the germinal vesicle, since it does not occur
in enucleated oocytes treated with progesterone (30). The re-
sults shown in Fig. 2 suggest that the mechanism for the re-
moval of the oligo(A) tail from histone mRNA may be distinct
from the removal of the poly(A) tails from other mRNAs.
Whether the same signal transduction pathway triggers these
events after progesterone treatment is not known. It is note-
worthy that these two deadenylation reactions have opposite
effects: translation of maternal adenylated mRNAs is inhib-
ited, while histone mRNA translation is activated. Whether the
signaling pathway that results in activation of histone mRNA
translation requires the Eg2 kinase (the critical regulator of
translation activation of polyadenylated mRNAs) is not
known.
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